Chesapeake PERL Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Chesapeake PERL General Information

Description

Operator of a biotechnology company intended to develop and produce proteins including humanized glycoproteins and therapeutics. The company's protein reagents are used for influenza, cholinesterase and other products, enabling customers to get proteins for human therapeutics including kinases, viral antigens, growth factors and antibodies.

Contact Information

Website
www.c-perl.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 8510 A Corridor Road
  • Savage, MD 20763
  • United States
+1 (301)
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 8510 A Corridor Road
  • Savage, MD 20763
  • United States
+1 (301)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chesapeake PERL Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-May-2016 Completed Out of Business
7. Grant 01-Jan-2012 Completed Generating Revenue
6. Debt - General 26-Jan-2010 Completed Profitable
5. Debt - General 04-Mar-2008 Completed Profitable
4. Later Stage VC 23-May-2005 Completed Generating Revenue
3. Grant 01-Jul-2004 Completed Generating Revenue
2. Early Stage VC 01-Jan-2001 Completed Startup
1. University Spin-Out 01-Jan-1998 Completed Startup
To view Chesapeake PERL’s complete valuation and funding history, request access »

Chesapeake PERL Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Chesapeake PERL Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080295774-A1 Automated packaging, inoculation, and harvesting of lepidopterous larvae for protein manufacturing Inactive 11-Feb-2005
EP-1824974-A2 Recovery of proteins from insect larvae Inactive 12-Nov-2004
CA-2587547-A1 Recovery of proteins from insect larvae Inactive 12-Nov-2004
JP-2008519855-A Protein recovery from insect larvae Pending 12-Nov-2004
US-20070067855-A1 Production of human glycosylated proteins in transgenic insects Inactive 28-Oct-2003 C12N15/8509
To view Chesapeake PERL’s complete patent history, request access »

Chesapeake PERL Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Chesapeake PERL FAQs

  • When was Chesapeake PERL founded?

    Chesapeake PERL was founded in 1998.

  • Where is Chesapeake PERL headquartered?

    Chesapeake PERL is headquartered in Savage, MD.

  • What is the size of Chesapeake PERL?

    Chesapeake PERL has 4 total employees.

  • What industry is Chesapeake PERL in?

    Chesapeake PERL’s primary industry is Biotechnology.

  • Is Chesapeake PERL a private or public company?

    Chesapeake PERL is a Private company.

  • What is Chesapeake PERL’s current revenue?

    The current revenue for Chesapeake PERL is .

  • How much funding has Chesapeake PERL raised over time?

    Chesapeake PERL has raised $2.39M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »